Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics

Fig. 3

Pathological correlation of 9 Tanshinone IIA-associated key hub genes. A1–A9: the nine key hub genes are associated with pathological T stage; B1–B9: the nine key hub genes are associated with pathological N stage; C1–C9: the nine key hub genes are associated with pathological Gleason score

Back to article page